Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gryningskust Holding is a Swedish private holding and investment company based in Stockholm. Public business-directory and company-profile sources describe it as an active investment or head-office company rather than an operating biotech, pharma, or healthcare developer. It appears to be known in life-science contexts primarily through its shareholdings in NeoDynamics, a cancer diagnostics and medtech company, including disclosures identifying Gryningskust as a major shareholder. There is no evidence that Gryningskust Holding itself develops therapeutic products, runs a clinical pipeline, or operates as a life-science services company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gryningskust Holding.